Jazz Pharmaceuticals Announces Private Offering Of $1.0 Billion Of Exchangeable Senior Notes Due 2032
JAZZ•Private offering and share repurchases
- Jazz Pharmaceuticals announces a private offering of $1.0 billion of exchangeable senior notes due 2032 and concurrent ordinary share repurchases.
- Initial purchasers may buy up to $150 million additional notes within 13 days.
- Jazz Pharmaceuticals expects to repurchase up to $225 million of ordinary shares concurrently.
- Net proceeds from the offering are expected to be used for general corporate purposes.
